Apr 24 |
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
|
Apr 2 |
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 12 |
Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point
|
Mar 10 |
Cantor sees strong year ahead for oncology M&A
|
Mar 5 |
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
|
Feb 23 |
Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
|
Feb 21 |
Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Feb 20 |
Bicycle Therapeutics GAAP EPS of -$1.16 beats by $0.15, revenue of $5.33M misses by $1.55M
|
Feb 20 |
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
|
Feb 13 |
Bicycle Therapeutics gains as former Seagen holder boosts stake
|